Literature DB >> 21675057

The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand.

A M Higgins1, V Pettilä, A H Harris, M Bailey, J Lipman, I M Seppelt, S A Webb.   

Abstract

The aim of this study was to determine the critical care and associated hospital costs for 2009 influenza A/H1N1 patients admitted to intensive care units (ICU) in Australia and New Zealand during the southern hemisphere winter All 762 patients admitted to ICUs in Australian and New Zealand between 1 June and 31 August 2009 with confirmed 2009 H1N1 influenza A were included. Costs were assigned based on ICU and hospital length-of-stay, using data from a single Australian ICU which estimated the daily cost of an ICU bed, along with published costs for a ward bed. Additional costs were assigned for allied health, overheads and extracorporeal membrane oxygenation services. The median (interquartile range) ICU and total hospital costs per patient were AU$35,942 ($10,269 to $82,152) and AU$51,294 ($22,849 to $110,340) respectively, while the mean (standard deviation) ICU and total hospital costs per patient were AU$63,298 ($78,722) and AU$85,395 ($147,457), respectively. A multivariate analysis found death was significantly associated with a reduction in the log of total costs, while the use of mechanical ventilation and ICU admission with viral pneumonitis/acute respiratory distress syndrome or secondary bacterial pneumonia were significantly associated with an increase in the log of total costs. The cost of 2009 H1N1 patients in ICU was significantly higher than the previously published costs for an average ICU admission, and the total cost of treating 2009 H1N1 patients in ICU admitted during winter 2009 was more than $65,000,000.

Entities:  

Mesh:

Year:  2011        PMID: 21675057     DOI: 10.1177/0310057X1103900308

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  9 in total

Review 1.  Impact of H1N1 on socially disadvantaged populations: summary of a systematic review.

Authors:  Andrea C Tricco; Erin Lillie; Charlene Soobiah; Laure Perrier; Sharon E Straus
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

2.  Real-Time Surveillance of Influenza Morbidity: Tracking Intensive Care Unit Resource Utilization.

Authors:  Arthur W Baker; Michael B Edmond; Loreen A Herwaldt; Luke F Chen; Sudha Srikantaswamy; Daniel J Sexton
Journal:  Ann Am Thorac Soc       Date:  2017-12

3.  Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice.

Authors:  Famke Aeffner; Anna Bratasz; Emilio Flaño; Kimerly A Powell; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-07       Impact factor: 6.914

Review 4.  Impact of H1N1 on socially disadvantaged populations: systematic review.

Authors:  Andrea C Tricco; Erin Lillie; Charlene Soobiah; Laure Perrier; Sharon E Straus
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

5.  Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England.

Authors:  Krystal Lau; Katharina Hauck; Marisa Miraldo
Journal:  Health Econ       Date:  2018-10-18       Impact factor: 3.046

6.  Cost-effectiveness of emergency preparedness measures in response to infectious respiratory disease outbreaks: a systematic review and econometric analysis.

Authors:  Constantine Vardavas; Katerina Nikitara; Konstantinos Zisis; Konstantinos Athanasakis; Revati Phalkey; Jo Leonardi-Bee; Helen Johnson; Svetla Tsolova; Massimo Ciotti; Jonathan E Suk
Journal:  BMJ Open       Date:  2021-04-29       Impact factor: 2.692

7.  Chaiqin Qingning Capsule Inhibits Influenza Virus Infection and Inflammation In Vitro and In Vivo.

Authors:  Jin Zhao; Yanbing Hao; Xuanzi Xia; Runfeng Li; Xiaodong Huang; Zifeng Yang; Xinhua Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-11       Impact factor: 2.629

8.  Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia.

Authors:  Carol L Hodgson; Kate Hayes; Tori Everard; Alistair Nichol; Andrew R Davies; Michael J Bailey; David V Tuxen; David J Cooper; Vin Pellegrino
Journal:  Crit Care       Date:  2012-10-19       Impact factor: 9.097

Review 9.  Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO.

Authors:  Alberto Zangrillo; Giuseppe Biondi-Zoccai; Giovanni Landoni; Giacomo Frati; Nicolò Patroniti; Antonio Pesenti; Federico Pappalardo
Journal:  Crit Care       Date:  2013-02-13       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.